A detailed history of Platform Technology Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Platform Technology Partners holds 9,205 shares of ABBV stock, worth $1.61 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
9,205
Previous 10,169 9.48%
Holding current value
$1.61 Million
Previous $2.01 Million 18.58%
% of portfolio
0.52%
Previous 0.64%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$164.99 - $203.87 $159,050 - $196,530
-964 Reduced 9.48%
9,205 $1.64 Million
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $45,875 - $55,812
-280 Reduced 2.68%
10,169 $2.01 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $132,500 - $154,730
856 Added 8.92%
10,449 $1.79 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $32,060 - $36,108
-233 Reduced 2.37%
9,593 $1.49 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $131,986 - $152,794
988 Added 11.18%
9,826 $1.46 Million
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $12,985 - $16,160
-98 Reduced 1.1%
8,838 $1.19 Million
Q1 2023

Apr 04, 2023

SELL
$144.61 - $166.54 $108,312 - $124,738
-749 Reduced 7.73%
8,936 $1.42 Million
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $16,735 - $20,070
-121 Reduced 1.23%
9,685 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $59,186 - $67,883
441 Added 4.71%
9,806 $1.32 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $127,711 - $162,362
-928 Reduced 9.02%
9,365 $1.43 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $30,883 - $38,317
234 Added 2.33%
10,293 $1.67 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $34,699 - $43,905
323 Added 3.32%
10,059 $1.36 Million
Q3 2021

Nov 04, 2021

SELL
$106.4 - $120.78 $296,749 - $336,855
-2,789 Reduced 22.27%
9,736 $1.05 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $11,257 - $12,541
107 Added 0.86%
12,525 $1.41 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $73,487 - $99,215
913 Added 7.94%
12,418 $1.33 Million
Q3 2020

Nov 30, 2020

BUY
$85.91 - $100.83 $687 - $806
8 Added 0.07%
11,505 $1.01 Million
Q2 2020

Nov 30, 2020

BUY
$73.37 - $98.18 $139,403 - $186,542
1,900 Added 19.8%
11,497 $1.13 Million
Q1 2020

Nov 30, 2020

BUY
$64.5 - $97.79 $183,825 - $278,701
2,850 Added 42.24%
9,597 $731,000
Q4 2019

Dec 03, 2020

BUY
$72.13 - $90.25 $486,661 - $608,916
6,747 New
6,747 $597,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Platform Technology Partners Portfolio

Follow Platform Technology Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.